Effect of acute and chronic liver diseases on the thyroid function in children

Gihan M Bebars1, Madeha A Sayed1, Lamia Hamdy2

  • 1Department of Pediatrics, Faculty of Medicine, Minia University, Minia, 61111, Egypt.

BMC Pediatrics
|August 26, 2021
PubMed

Insights

Thyroid function is altered in children with acute and chronic liver disease. Thyroid hormone levels correlate with disease severity, indicating a significant impact of liver conditions on thyroid health in pediatric patients.

Area of Science:

  • Pediatric Endocrinology
  • Hepatology
  • Thyroidology

Background:

  • Thyroid hormones regulate metabolic rate and liver function.
  • The liver is crucial for thyroid hormone metabolism and endocrine regulation.
  • Liver disease can disrupt normal thyroid hormone homeostasis.

Purpose of the Study:

  • To evaluate thyroid function in children diagnosed with acute and chronic liver diseases.
  • To investigate the relationship between liver disease severity and thyroid function parameters.

Main Methods:

  • 85 children were categorized into four groups: acute hepatitis (AH), chronic liver disease (CLD1, CLD2), and controls.
  • Comprehensive assessments included medical history, physical exams, and laboratory tests (CBC, liver/renal function, viral markers).
  • Thyroid function tests (Free T3, Free T4, TSH) were performed on all participants.

Main Results:

  • Children with AH, CLD1, and CLD2 exhibited lower Free T3 levels.
  • TSH levels were significantly elevated in the CLD2 group (severe chronic liver disease).
  • Correlations were observed between thyroid hormones, liver enzymes (AST), lipid profiles (VLDL, LDL), and coagulation parameters (prothrombin concentration, PT).

Conclusions:

  • Both acute and chronic liver diseases significantly impact thyroid function in children.
  • The degree of thyroid dysfunction is associated with the severity of the liver disease.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
36
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
3.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
34
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
5.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
27